Literature DB >> 1942955

Excessive hypernatremia in a patient with renal amyloid disease.

T Schorn1, H Manschwetus, K W Kühn.   

Abstract

A 24-year-old Italian male presented with a nephrotic syndrome in September 1984. In February 1985 renal biopsy showed amyloid disease with tubular atrophy and interstitial fibrosis. Edema was treated with furosemide, and cholchicine was started. Because he feared side effects of drug therapy, the patient stopped all medication by July 1985. Instead, he decided to restrict severely fluids in order to fight edema. In early November 1985 his family noted he was becoming increasingly lethargic. Two weeks later, on his admission to the hospital, he had a serum sodium concentration of 193 mmol/l and serum osmolality of 397 mosm/kg. Apart from mild mental status changes neurological examination was normal. The fluid deficit was slowly corrected. He was discharged three weeks later with normal serum electrolytes. This case demonstrates that (1) severe hypernatremia can present with mild neurological symptoms and (2) it can be survived provided that it develops slowly and is corrected cautiously.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942955     DOI: 10.1007/bf01666829

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  7 in total

1.  Effects on the central nervous system of hypernatremic and hyponatremic states.

Authors:  A I Arieff; R Guisado
Journal:  Kidney Int       Date:  1976-07       Impact factor: 10.612

2.  Nephrogenic diabetes insipidus caused by amyloid disease. Evidence in man of the role of the collecting ducts in concentrating urine.

Authors:  F A CARONE; F H EPSTEIN
Journal:  Am J Med       Date:  1960-09       Impact factor: 4.965

Review 3.  Severe hypernatremia with impaired thirst.

Authors:  G O Perez; J R Oster; G L Robertson
Journal:  Am J Nephrol       Date:  1989       Impact factor: 3.754

4.  Hypodipsic hypernatremia with normal osmoregulation of vasopressin.

Authors:  D N Hammond; G W Moll; G L Robertson; E Chelmicka-Schorr
Journal:  N Engl J Med       Date:  1986-08-14       Impact factor: 91.245

5.  A case of 'essential' hypernatraemia due to resetting of the osmostat.

Authors:  G Gill; P Baylis; J Burn
Journal:  Clin Endocrinol (Oxf)       Date:  1985-04       Impact factor: 3.478

6.  [Severe hypernatremia in acquired disorder of thirst and vasopressin regulation].

Authors:  J Hensen; V Bähr; W Oelkers
Journal:  Klin Wochenschr       Date:  1988-06-01

7.  Survival with severe hypernatremia.

Authors:  R C Goldszer; E L Coodley
Journal:  Arch Intern Med       Date:  1979-08
  7 in total
  3 in total

Review 1.  Regulation of Inflammatory Functions of Macrophages and T Lymphocytes by NFAT5.

Authors:  Jose Aramburu; Cristina López-Rodríguez
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

2.  Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice.

Authors:  Beatriz Morancho; Jordi Minguillón; Jeffery D Molkentin; Cristina López-Rodríguez; Jose Aramburu
Journal:  BMC Mol Biol       Date:  2008-01-25       Impact factor: 2.946

3.  The transcription factor NFAT5 is required for cyclin expression and cell cycle progression in cells exposed to hypertonic stress.

Authors:  Katherine Drews-Elger; M Carmen Ortells; Anjana Rao; Cristina López-Rodriguez; Jose Aramburu
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.